⌘K

Login Start Free

Home/Filings/6-K/0001213900-26-001970

6-K//Foreign company update

PURPLE BIOTECH LTD. 6-K

Accession 0001213900-26-001970

$PPBTCIK 0001614744other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 8:05 AM ET

Size

29.0 KB

Accession

0001213900-26-001970

Documents

2 files

6-K
ea0272026-6k_purple.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea027202601ex99-1_purple.htm
PURPLE BIOTECH ACHIEVES TOXICOLOGY MILESTONE DEMONSTRATING AN EXPANDED THERAPEUTIC WINDOW FOR CAPTN-3 PLATFORM TRI-SPECIFIC ANTIBODY, IM1240

Issuer

PURPLE BIOTECH LTD.

CIK 0001614744

Entity typeother

IncorporatedIsrael

Related Parties

1

filerCIK 0001614744

Filing Metadata

Form type: 6-K
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 8:05 AM ET
Size: 29.0 KB

View on SEC.gov